Counterfeit Ozempic injection pen warning


Consumers warned of potential risks of counterfeit injection pens sold as Ozempic  Patients are being urged not to use Ozempic (semaglutide) bearing the batch number MPSD916, after the Australian Border Force seized counterfeit products. The Therapeutic Goods Administration (TGA) has issued a warning that the counterfeit pen “may pose a serious risk to” health “and

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Show

Forgot Password?Why do I need to login & stay in?

Previous MedAdvisor considering options to shore up revenue
Next Calls for more targeted drug dependency funding